Details for Patent: 9,724,471
✉ Email this page to a colleague
Which drugs does patent 9,724,471 protect, and when does it expire?
Patent 9,724,471 protects EVZIO and EVZIO (AUTOINJECTOR) and is included in two NDAs.
This patent has one hundred and six patent family members in fourteen countries.
Summary for Patent: 9,724,471
| Title: | Devices, systems, and methods for medicament delivery |
| Abstract: | Certain exemplary embodiments comprise can comprise an auto-injector, which can comprise: a vial configured to store and/or contain an injectable medicament, the vial defining a vial longitudinal axis, and a housing comprising the vial. In various embodiments, the injectable medicament can be a medicine, medication, drug, pharmaceutical, prescriptive, agent, antidote, anti-venom, hormone, stimulant, vasodilator, anesthetic, and/or nutritional supplement that is substantially ready for injection. |
| Inventor(s): | Edwards; Evan T. (Charlottesville, VA), Edwards; Eric S. (Moseley, VA), Licata; Mark J. (Doswell, VA) |
| Assignee: | kaleo, Inc. (Richmond, VA) |
| Application Number: | 14/244,311 |
|
Patent Claim Types: see list of patent claims | Use; Device; Dosage form; |
Recent additions to Drugs Protected by US Patent 9,724,471
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Req. | Patent Expiration | Usecode | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Req. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |
Drugs Protected by US Patent 9,724,471
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD FOR CONFIRMING DOSE DELIVERY | ⤷ Try a Trial | |||
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD FOR CONFIRMING DOSE DELIVERY | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,724,471
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2004325202 | ⤷ Try a Trial | |||
| Australia | 2006210865 | ⤷ Try a Trial | |||
| Australia | 2007245139 | ⤷ Try a Trial | |||
| Australia | 2009200841 | ⤷ Try a Trial | |||
| Australia | 2009246525 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
